69-drugs[.]com

This domain is flagged as an elevated-risk online pharmacy phishing site, designed to deceive users into purchasing counterfeit or unauthorized pharmaceutical products. Analysis indicates the site mimics legitimate pharmacy services, leveraging social engineering tactics to exploit trust in online medical transactions. The specific threat type—generic_phishing with a pharmaceutical focus—targets individuals seeking cost-effective medications, increasing the likelihood of financial fraud or exposure to harmful substances. Infrastructure analysis reveals multiple high-risk indicators. The domain 69-drugs.com was registered on February 23, 2026, through NiceNIC International Group Co., Limited, a registrar often associated with illicit online activities. It resolves to the IP address 91.202.233.53, which has been linked to prior malicious campaigns. Security vendors on VirusTotal flagged the domain at a rate of 4/95, while Scamadviser and Gridinsoft assigned trust scores of 1/100 and 0/100, respectively. The domain appears on one security blocklist and is currently offline, though its prior activity warrants continued monitoring. Detected technologies include Ubuntu, Nginx, jQuery Migrate, and jQuery, with a Let’s Encrypt SSL certificate providing minimal encryption. Mitigation steps for this threat type include blocking the domain and its associated IP (91.202.233.53) at the network perimeter. Organizations should update endpoint detection rules to flag similar online pharmacy phishing attempts, particularly those using newly registered domains or low-trust indicators. User awareness training should emphasize the risks of unlicensed pharmaceutical sites, including financial fraud and potential exposure to counterfeit drugs. Security teams are advised to monitor for related domains registered under the same registrar or resolving to the same IP range, as threat actors frequently reuse infrastructure.